Well you guys are being more mature than the PSDV board. Some people sold and went in again to gain some back on the rising and falling price and try to scrap what they lost. I don't understand the FDA's response. It's the same thing they said in 2011 almost so that's what they concentrated on. I don't know if they did the trials over, but used the old data and focused on the safety aspect. I still feel bad for any bio tech company that's trying to make the world better. They need grants or investors and the government to work with them and our's is one of the most difficult in the world. Sadly the price of their services and hyped up when most of the work they do consists of pushing a paper while you stand in a cue for years and they get overpaid and spoiled forgetting how fortunate they are to have that position.
They need to open their doors more and be more accessible and more of a helper than on a pedistal. Every thing provided is overpriced. They will leave you waiting your whole life and just waste it away. They were the best, but they hurt the medical community more than help it. I think over the past few years they've lightened up bc of Obama pushing for more funding and the recent attacks on the FDA in past years by Michael Moore. More and more people start looking elsewhere for medical treatment where it's gaining on us or surpassed bc the gov worked with them. The medical team is international, but it's the gov that keeps stalls the progress.
The rest of the world is still available. Europe and UK now, Australia, Canada someday (although like UK, France etc with free healthcare cause payout problems. Profits will come. The FDA validation would have been nice but this sell-off is way overdone. There is still opportunity for a big pharma to gobble up ALIM and PSDV...I wish for this and will hold on to my 34000 shares.